OBR Green Articles (Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis))


June 2018Edition

The enthusiasm for the new CAR-Ts Kymriah and Yescarta has been dampened by limited patient access and uncertainties about cost and reimbursement. As CMS and other payers grapple with coverage decisions, the long-term economic sustainability of these...